Cantourage Group SE Logo

Cantourage Group SE

ISIN: DE000A3DSV01 | Ticker: HIGH | LEI: 3912003NCTLO6YHA9V48
Sector: Consumer StaplesSub-Industry: Tobacco
Country: Germany

About Cantourage Group SE

Company Description

Cantourage is a publicly listed, leading European medical cannabis company. The Berlin-based company with subsidiaries in the United Kingdom and Poland, was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. Cantourage enables producers from all over the world to become part of the rapidly growing European medical cannabis market in a faster and more cost-effective way, while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol. The company was listed on the Frankfurt Stock Exchange on 11 November 2022 and is listed under the stock ticker “HIGH”.

Year founded

2019

Served area

Europe

Headquarters

Feurigstraße 54, 10827 Berlin – Germany

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
17.05.24 HOFY4 GmbH Close relation Sell EUR 140,000.00
17.05.24 HOFY4 GmbH Close relation Sell EUR 1,080.00
21.02.24 HOFY4 GmbH Close relation Sell EUR 63,205.88
14.02.24 Think.Health Projekt M GmbH & Co. KG Close relation Sell EUR 82,415.57
14.02.24 Think.Health Projekt M GmbH & Co. KG Close relation Sell EUR 4,005.00
07.09.23 CDXX Vermögens- und Verwaltungs GmbH Close relation Sell EUR 105,490.00
17.08.23 HOFY4 GmbH Close relation Sell EUR 40,023.24
17.08.23 HOFY4 GmbH Close relation Sell EUR 14,257.90
20.06.23 HOFY4 GmbH Close relation Sell EUR 80,519.46
14.06.23 HOFY4 GmbH Close relation Sell EUR 1,658.50

Capital markets information

ISIN

DE000A3DSV01

LEI

3912003NCTLO6YHA9V48

Sector

Consumer Staples

Industry Group

Food, Beverage & Tobacco

Industry

Tobacco

Sub-Industry

Tobacco

Listed Stock Exchange

Borsa Italiana

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.